Stefania Cuzzubbo

40.1k total citations · 1 hit paper
27 papers, 833 citations indexed

About

Stefania Cuzzubbo is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stefania Cuzzubbo has authored 27 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Genetics and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stefania Cuzzubbo's work include Glioma Diagnosis and Treatment (10 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immunotherapy and Immune Responses (9 papers). Stefania Cuzzubbo is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immunotherapy and Immune Responses (9 papers). Stefania Cuzzubbo collaborates with scholars based in France, Italy and United Kingdom. Stefania Cuzzubbo's co-authors include Alain Carpentier, Rénata Ursu, Cathérine Belin, Célèste Lebbé, Jennifer Doridam, Stéphanie McArdle, A. Graham Pockley, Divya Nagarajan, Sara M. Mangsbo and Chris J. Tinsley and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and International Journal of Molecular Sciences.

In The Last Decade

Stefania Cuzzubbo

25 papers receiving 820 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature

2017 397 citations Stefania Cuzzubbo, Jennifer Doridam et al. European Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefania Cuzzubbo France	12	548	279	243	211	165	27	833
Samuel Haile United States	10	559 1.0×	65 0.2×	188 0.8×	366 1.7×	202 1.2×	14	885
Jeremy Rudnick United States	10	314 0.6×	108 0.4×	453 1.9×	268 1.3×	178 1.1×	36	844
Xin Tang China	17	674 1.2×	97 0.3×	204 0.8×	399 1.9×	246 1.5×	35	1.1k
Russell Maxwell United States	11	259 0.5×	108 0.4×	187 0.8×	191 0.9×	81 0.5×	32	496
Sylvia C. Kurz United States	12	207 0.4×	125 0.4×	199 0.8×	109 0.5×	148 0.9×	33	538
Carole Ramirez France	9	217 0.4×	77 0.3×	203 0.8×	103 0.5×	272 1.6×	23	704
Ekaterina Friebel Switzerland	8	358 0.7×	99 0.4×	231 1.0×	594 2.8×	272 1.6×	11	987
David Foulad United States	13	481 0.9×	90 0.3×	113 0.5×	371 1.8×	414 2.5×	17	1.0k
Benjamin Himes United States	15	188 0.3×	94 0.3×	310 1.3×	206 1.0×	411 2.5×	36	932

Countries citing papers authored by Stefania Cuzzubbo

Since Specialization

Citations

This map shows the geographic impact of Stefania Cuzzubbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Cuzzubbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Cuzzubbo more than expected).

Fields of papers citing papers by Stefania Cuzzubbo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Cuzzubbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Cuzzubbo. The network helps show where Stefania Cuzzubbo may publish in the future.

Co-authorship network of co-authors of Stefania Cuzzubbo

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Cuzzubbo. A scholar is included among the top collaborators of Stefania Cuzzubbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Cuzzubbo. Stefania Cuzzubbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ursu, Rénata, Roberta Di Blasi, Cathérine Belin, et al.. (2025). Baseline Cognitive and Neurological Status Does Not Modify the Occurrence of ICANS in CAR T‐Cell Therapy for Aggressive B‐Cell Lymphoma. European Journal of Neurology. 32(6). e70236–e70236. 1 indexed citations

Ursu, Rénata, Stefania Cuzzubbo, & Alain Carpentier. (2025). Neurotoxicity from chimeric antigen receptor T-cells: an update on diagnosis and treatment. Current Opinion in Neurology. 38(6). 688–694.

Belin, Cathérine, et al.. (2024). CAR T-cell-associated neurotoxicity: A comprehensive review. Revue Neurologique. 180(9). 989–994. 3 indexed citations

Pïcca, Alberto, Stefania Cuzzubbo, Elizabeth Cohen‐Jonathan Moyal, et al.. (2024). REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas. European Journal of Cancer. 202. 114034–114034. 3 indexed citations

Kacimi, Salah Eddine Oussama, Caroline Dehais, L. Feuvret, et al.. (2024). Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma.. Journal of Clinical Oncology. 42(16_suppl). 2004–2004. 1 indexed citations

Cuzzubbo, Stefania, et al.. (2023). P06.17.A OPTIC NEUROPATHY RELATED TO IMMUNE CHECKPOINT INHIBITORS: A CASE SERIES. Neuro-Oncology. 25(Supplement_2). ii49–ii49.

Ursu, Rénata, Didier Maillet, Cathérine Belin, et al.. (2022). Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Neurology. 99(12). 511–515. 20 indexed citations

Cuzzubbo, Stefania, Benoît Roch, Guillaume Darrasse-Jèze, et al.. (2022). Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy. International Journal of Molecular Sciences. 23(23). 14975–14975. 3 indexed citations

Cuzzubbo, Stefania & Alain Carpentier. (2022). Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatment. Current Opinion in Neurology. 35(6). 814–822. 8 indexed citations

10.

Cuzzubbo, Stefania, et al.. (2021). Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments. Frontiers in Immunology. 11. 615240–615240. 89 indexed citations

11.

Ursu, Rénata, Jennifer Doridam, Cathérine Belin, et al.. (2021). Predictive factors of human cytomegalovirus reactivation in newly diagnosed glioblastoma patients treated with chemoradiotherapy. Journal of NeuroVirology. 27(1). 94–100. 3 indexed citations

12.

Maillet, Didier, Cathérine Belin, Christine Moroni, et al.. (2021). Evaluation of mid-term (6-12 months) neurotoxicity in B-cell lymphoma patients treated with CAR T cells: a prospective cohort study. Neuro-Oncology. 23(9). 1569–1575. 29 indexed citations

13.

Cuzzubbo, Stefania, Claire Banissi, Thi Tran, et al.. (2020). The adjuvant effect of melanin is superior to incomplete Freund’s adjuvant in subunit/peptide vaccines in mice. Cancer Immunology Immunotherapy. 69(12). 2501–2512. 8 indexed citations

14.

Pearson, Joshua R. D., Stefania Cuzzubbo, Simon McArthur, et al.. (2020). Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment. Frontiers in Immunology. 11. 582106–582106. 80 indexed citations

15.

Cuzzubbo, Stefania, Sarah Guégan, Rénata Ursu, et al.. (2020). Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients. Journal for ImmunoTherapy of Cancer. 8(2). e001034–e001034. 20 indexed citations

16.

Ursu, Rénata, Laure Thomas, Dimitri Psimaras, et al.. (2019). Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study. European Journal of Cancer. 109. 129–136. 13 indexed citations

17.

Cuzzubbo, Stefania, Cathérine Belin, Kader Chouahnia, et al.. (2018). Assessing cognitive function in patients treated with immune checkpoint inhibitors: A feasibility study. Psycho-Oncology. 27(7). 1861–1864. 13 indexed citations

18.

Cuzzubbo, Stefania, Jennifer Doridam, Célèste Lebbé, et al.. (2017). Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature. European Journal of Cancer. 73. 1–8. 397 indexed citations breakdown →

19.

Cuzzubbo, Stefania, et al.. (2016). P04.08 Neurological adverse events associated with the immune checkpoint inhibitors: review of the literature and characterization of the neurological patterns. Neuro-Oncology. 18(suppl_4). iv25–iv26. 2 indexed citations

20.

Finocchiaro, Gaetano, Marica Eoli, Serena Pellegatta, et al.. (2015). IMCT-06SURVIVAL GAIN AND IMMUNE RESPONSE IN GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY BEFORE AND DURING ADJUVANT TEMOZOLOMIDE. Neuro-Oncology. 17(suppl 5). v108.2–v108. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact